Pentosidine accumulation induced by Akr1a deficiency drives aggression and hyperactivity

Area of Science:

• Neuroscience
• Metabolic Biochemistry
• Disease Modeling

Background:

• Advanced glycation end products (AGEs) accumulate under metabolic stress, contributing to chronic diseases and aging.
• Pentosidine (PEN), a specific AGE, is elevated in some schizophrenia patients, correlating with worse outcomes.
• Impaired glucuronic acid (GlcA) metabolism, potentially due to reduced AKR1A1 activity, may cause PEN accumulation.

Purpose of the Study:

• To investigate the neurobiological effects of endogenous PEN accumulation.
• To examine the behavioral consequences of impaired GlcA metabolism using Akr1a knockout mice.

Main Methods:

• Utilized Akr1a knockout mice exhibiting impaired GlcA metabolism.
• Measured PEN levels in plasma and prefrontal cortex (Pfc).
• Assessed neurobehavioral outcomes including aggression and locomotor activity.
• Performed transcriptomic analysis of the Pfc and measured cyclic guanosine monophosphate (cGMP) levels.

Main Results:

• Akr1a knockout mice showed elevated PEN in plasma and Pfc.
• These mice displayed increased aggression and hyperactivity, relevant to schizophrenia.
• Aggression positively correlated with PEN levels.
• Pfc transcriptomics revealed altered gene expression in guanylate cyclase signaling, cytoskeletal organization, and immune response pathways.
• Reduced cGMP levels indicated impaired downstream signaling.

Conclusions:

• GlcA-driven PEN accumulation induces molecular and behavioral changes in the brain.
• Akr1a knockout mice provide a valuable model for studying glycation-related metabolic stress in schizophrenia.
• This model links metabolic dysfunction to aggression and hyperactivity relevant to schizophrenia pathophysiology.